Literature DB >> 18827871

The difference between ballistocardiography and stem cells.

P A Doevendans1, E van Belle.   

Abstract

Year:  2008        PMID： 18827871      PMCID： PMC2553153          DOI： 10.1007/bf03086166

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  13 in total

Review 1.  Stem cell therapy for ischemic heart disease.

Authors:  Rutger J Hassink; Joshua D Dowell; Aart Brutel de la Rivière; Pieter A Doevendans; Loren J Field
Journal:  Trends Mol Med       Date:  2003-10       Impact factor: 11.951

Review 2.  Human stem cells shape the future of cardiac regeneration research.

Authors:  Rutger J Hassink; Marie Jose Goumans; Christine L Mummery; Pieter A Doevendans
Journal:  Int J Cardiol       Date:  2004-06       Impact factor: 4.164

3.  Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources.

Authors:  C Qian; R G Schoemaker; W H van Gilst; B Yu; A J M Roks
Journal:  Neth Heart J       Date:  2008-09       Impact factor: 2.380

4.  Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy.

Authors:  P van Vliet; M Roccio; A M Smits; A A M van Oorschot; C H G Metz; T A B van Veen; J P G Sluijter; P A Doevendans; M-J Goumans
Journal:  Neth Heart J       Date:  2008-05       Impact factor: 2.380

5.  Somatic stem cells and cardiac repair: where is the science?

Authors:  M J Goumans; P A Doevendans; D Atsma; C Mummery
Journal:  Neth Heart J       Date:  2004-12       Impact factor: 2.380

Review 6.  Transplantation of cells for cardiac repair.

Authors:  Rutger J Hassink; Aart Brutel de la Rivière; Christine L Mummery; Pieter A Doevendans
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

7.  Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

Authors:  Alexander Hirsch; Robin Nijveldt; Pieter A van der Vleuten; Bart J Biemond; Pieter A Doevendans; Albert C van Rossum; Jan G Tijssen; Felix Zijlstra; Jan J Piek
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

Review 8.  Estrogenic hormone action in the heart: regulatory network and function.

Authors:  Fawzi A Babiker; Leon J De Windt; Martin van Eickels; Christian Grohe; Rainer Meyer; Pieter A Doevendans
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

9.  Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives.

Authors:  C Qian; R G Schoemaker; W H van Gilst; B Yu; A J M Roks
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

10.  TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro.

Authors:  Marie-José Goumans; Teun P de Boer; Anke M Smits; Linda W van Laake; Patrick van Vliet; Corina H G Metz; Tom H Korfage; K Peter Kats; Ron Hochstenbach; Gerard Pasterkamp; Marianne C Verhaar; Marcel A G van der Heyden; Dominique de Kleijn; Christine L Mummery; Toon A B van Veen; Joost P G Sluijter; Pieter A Doevendans
Journal:  Stem Cell Res       Date:  2008-03-12       Impact factor: 2.020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.